Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Lantern Pharma (LTRN) Q4 2025 Earnings
LTRN
13
Nov
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.54
-0.49
-0.44
-0.39
Details
Expected EPS
-0.47
Actual EPS
-0.39
Surprise EPS
0.08
Surprise Percent
+17.02%
Description
Lantern Pharma (LTRN) has reported earnings of -0.39 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login